Comparative effectiveness of one versus two doses of COVID-19 vaccines in Qatar: Evidence of converging protection over time

<h3 dir="ltr">Background</h3><p dir="ltr">Supply constraints during the coronavirus disease 2019 (COVID-19) pandemic led to vaccination strategies that prioritized first-dose coverage. To evaluate the merit of this approach, this study compared the development o...

Full description

Saved in:

Bibliographic Details
Main Author:	Hiam Chemaitelly (439114) (author)
Other Authors:	Houssein H. Ayoub (9262512) (author), Peter Coyle (787159) (author), Patrick Tang (239534) (author), Mohammad R. Hasan (13777597) (author), Hadi M. Yassine (4675846) (author), Asmaa A. Al Thani (10494576) (author), Zaina Al-Kanaani (4557205) (author), Einas Al-Kuwari (13777606) (author), Andrew Jeremijenko (11506565) (author), Anvar Hassan Kaleeckal (11847034) (author), Ali Nizar Latif (11570540) (author), Riyazuddin Mohammad Shaik (11847037) (author), Hanan F. Abdul-Rahim (13777600) (author), Gheyath K. Nasrallah (9200525) (author), Mohamed Ghaith Al-Kuwari (4264192) (author), Adeel A. Butt (3697705) (author), Hamad Eid Al-Romaihi (6837251) (author), Mohamed H. Al-Thani (11847049) (author), Abdullatif Al-Khal (11721410) (author), Laith J. Abu-Raddad (9262524) (author)
Published:	2025
Subjects:	Biomedical and clinical sciences Clinical sciences Immunology Health sciences Epidemiology Public health Case-control Test-negative Immunity BNT162b2 mRNA-1273 ChAdOx1 nCoV-19
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Comparative effectiveness of one versus two doses of COVID-19 vaccines in Qatar: Evidence of converging protection over time

Similar Items